Semaphorins and their receptors in pancreatic cancer: Mechanisms and therapeutic opportunities

被引：5

作者：

Liu, Dahai ^{[1
]}

Li, Jie ^{[1
]}

Qi, Fei ^{[2
]}

You, Hua ^{[3
,4
]}

机构：

[1] Foshan Univ, Sch Med, Foshan, Guangdong, Peoples R China

[2] Peking Univ Shenzhen Hosp, Dept Pulm & Crit Care Med, Shenzhen, Peoples R China

[3] Chongqing Med Univ, Childrens Hosp, Dept Pediat Hematol & Oncol, Chongqing, Peoples R China

[4] Childrens Hosp Chongqing Med Univ, Natl Clin Res Ctr Child Hlth & Disorders, Lab Excellence Syst Biomed Pediat Oncol, Chongqing Key Lab Pediat,Minist Educ Key Lab Chi, Chongqing, Peoples R China

来源：

FRONTIERS IN ONCOLOGY | 2023年 / 12卷

基金：

中国国家自然科学基金;

关键词：

pancreatic cancer; semaphorins; mechanisms; Sema3; Sema4D; ANTIBODY BLOCKADE; TUMOR-GROWTH; 4D; METASTASIS; NEUROPILIN-1; PROGRESSION; EXPRESSION; INVASION; BINDING; 3C;

D O I：

10.3389/fonc.2022.1106762

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Pancreatic cancer (PC) is a malignant tumor with high malignancy that is difficult to diagnose and treat. PC is a major medical problem because of its low early diagnosis rate, high surgical mortality rate, low cure rate, and expensive related testing cost. Therefore, the significance of finding new markers for PC is self-evident. Semaphorins (Semas) have been shown to affect angiogenesis and lymphangiogenesis and can also directly affect the behavior of tumor cells. The expression and related action targets of its family members on PC are summarized in this review.

引用

页数：7

共 52 条

[21] Semaphorin 3C is involved in the progression of gastric cancer [J].

Miyato, Hideyo ;

Tsuno, Nelson Hirokazu ;

Kitayama, Joji .

CANCER SCIENCE, 2012, 103 (11) :1961-1966

[22] Association of axon guidance factor Semaphorin 3A with poor outcome in pancreatic cancer [J].

Mueller, Michael W. ;

Giese, Nathalia A. ;

Swiercz, Jakub M. ;

Ceyhan, Gueralp O. ;

Esposito, Irene ;

Hinz, Ulf ;

Buechler, Peter ;

Giese, Thomas ;

Buechler, Markus W. ;

Offermanns, Stefan ;

Friess, Helmut .

INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (11) :2421-2433

[23] Targeting Sema3D in pancreatic cancer: A novel therapeutic strategy [J].

Murphy, Adrian ;

Kleponis, Jennifer ;

Rucki, Agnieszka ;

Jaffee, Elizabeth M. ;

Zheng, Lei ;

Foley, Kelly .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)

[24] Semaphorins in Angiogenesis and Tumor Progression [J].

Neufeld, Gera ;

Sabag, Adi D. ;

Rabinovicz, Noa ;

Kessler, Ofra .

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (01)

[25] Identification of Semaphorin3B as a direct target of p53 [J].

Ochi, K ;

Mori, T ;

Toyama, Y ;

Nakamura, Y ;

Arakawa, H .

NEOPLASIA, 2002, 4 (01) :82-87

[26] Semaphorin 7A promotes axon outgrowth through integrins and MAPKs [J].

Pasterkamp, RJ ;

Peschon, JJ ;

Spriggs, MK ;

Kolodkin, AL .

NATURE, 2003, 424 (6947) :398-405

[27] Semaphorin junction: making tracks toward neural connectivity [J].

Pasterkamp, RJ ;

Kolodkin, AL .

CURRENT OPINION IN NEUROBIOLOGY, 2003, 13 (01) :79-89

[28] Cyclin D1, cancer progression, and opportunities in cancer treatment [J].

Qie, Shuo ;

Diehl, J. Alan .

JOURNAL OF MOLECULAR MEDICINE-JMM, 2016, 94 (12) :1313-1326

[29]

Ren KK., 2020, J MED POSTGRADUATES, V12, P169, DOI [10.16571/j.cnki.1008-8199.2020.02.012, DOI 10.16571/J.CNKI.1008-8199.2020.02.012]

[30]

Ru JJ., 2018, CHIN J CLIN HEPATOL, V34, P350, DOI [10.3969/j.issn.1001-5256.2018.02.026, DOI 10.3969/J.ISSN.1001-5256.2018.02.026]

← 1 2 3 4 5 6 →